Literature DB >> 23306781

Optimization of human umbilical cord mesenchymal stem cell isolation and culture methods.

Yan-Fu Han1, Ran Tao, Tian-Jun Sun, Jia-Ke Chai, Guang Xu, Jing Liu.   

Abstract

Human umbilical cord mesenchymal stem cells (hUCMSCs) are considered to be an ideal replacement for bone marrow MSCs. However, up to date, there is no convenient and efficient method for hUCMSC isolation and culture. The present study was carried out to explore the modified enzyme digestion for hUCMSC in vitro. Conventional enzyme digestion, modified enzyme digestion, and tissue explant were used on hUCMSCs to compare their efficiencies of isolation and culture, to observe primary cell growth and cell subculture. The results show that the cells cultured using the tissue explant method had a longer culture cycle (P < 0.01) and lower yield of primary cells per centimetre of umbilical cord (P < 0.01) compared with the two enzyme digestion methods. Subculture adherence and cell doubling took significantly less time with the tissue explant method (P < 0.05) than with the conventional enzyme digestion method; however, there was no significant difference between the tissue explant method and the modified enzyme digestion method (P > 0.05). Comparing two enzyme digestion methods, the modified method yielded more cells than did the conventional method (P < 0.01), and primary cell adherence took significantly less time with the modified method than with the conventional method (P < 0.05). Cell cycle analysis of the third-generation hUCMSCs cultured by modified enzyme digestion method indicated that most cells were quiescent. Immunofluorescence staining showed that these cells expressed MSC markers CD44 and CD90. And Von Kossa and oil red O staining detection showed that they could be differentiated into osteoblasts and adipocytes with induction medium in vitro. This study suggests that hUCMSC isolation and culture using 0.2 % collagenase II at 37 °C for digestion of 16-20 h is an effective and simple modified enzyme digestion method.

Entities:  

Year:  2013        PMID: 23306781      PMCID: PMC3967601          DOI: 10.1007/s10616-012-9528-0

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  23 in total

1.  Isolation of multipotent mesenchymal stem cells from umbilical cord blood.

Authors:  Oscar K Lee; Tom K Kuo; Wei-Ming Chen; Kuan-Der Lee; Shie-Liang Hsieh; Tain-Hsiung Chen
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

2.  Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method.

Authors:  Chih Kong Tong; Shalini Vellasamy; Boon Chong Tan; Maha Abdullah; Sharmili Vidyadaran; Heng Fong Seow; Rajesh Ramasamy
Journal:  Cell Biol Int       Date:  2011-03       Impact factor: 3.612

3.  Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord.

Authors:  Hwai-Shi Wang; Shih-Chieh Hung; Shu-Tine Peng; Chun-Chieh Huang; Hung-Mu Wei; Yi-Jhih Guo; Yu-Show Fu; Mei-Chun Lai; Chin-Chang Chen
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

4.  Method to isolate mesenchymal-like cells from Wharton's Jelly of umbilical cord.

Authors:  Kiran Seshareddy; Deryl Troyer; Mark L Weiss
Journal:  Methods Cell Biol       Date:  2008       Impact factor: 1.441

5.  Differentiation of human umbilical cord mesenchymal stem cells into dermal fibroblasts in vitro.

Authors:  Yanfu Han; Jiake Chai; Tianjun Sun; Dongjie Li; Ran Tao
Journal:  Biochem Biophys Res Commun       Date:  2011-09-08       Impact factor: 3.575

6.  Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells.

Authors:  Angela Kortesidis; Andrew Zannettino; Sandra Isenmann; Songtao Shi; Tsvee Lapidot; Stan Gronthos
Journal:  Blood       Date:  2005-01-27       Impact factor: 22.113

7.  Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow.

Authors:  Dolores Baksh; Raphael Yao; Rocky S Tuan
Journal:  Stem Cells       Date:  2007-03-01       Impact factor: 6.277

8.  Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion.

Authors:  Melissa A Baxter; Robert F Wynn; Simon N Jowitt; J Ed Wraith; Leslie J Fairbairn; Ilaria Bellantuono
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

9.  Study on myofibroblast differentiation in the stromal cells of Wharton's jelly: expression and localization of alpha-smooth muscle actin.

Authors:  K Kobayashi; T Kubota; T Aso
Journal:  Early Hum Dev       Date:  1998-07-10       Impact factor: 2.079

10.  Human mesenchymal stem cells isolated from the umbilical cord.

Authors:  Chun Qiao; Wenrong Xu; Wei Zhu; Jiabo Hu; Hui Qian; Qing Yin; Runqiu Jiang; Yongmin Yan; Fei Mao; Huan Yang; Xingzhong Wang; Yongchang Chen
Journal:  Cell Biol Int       Date:  2007-08-19       Impact factor: 3.612

View more
  25 in total

1.  Double labelling of human umbilical cord mesenchymal stem cells with Gd-DTPA and PKH26 and the influence on biological characteristics of hUCMSCs.

Authors:  Hanlin Shuai; Changzheng Shi; Jifa Lan; Danliang Chen; Xin Luo
Journal:  Int J Exp Pathol       Date:  2015-02-04       Impact factor: 1.925

2.  Multipotent mesenchymal stromal cells are fully permissive for human cytomegalovirus infection.

Authors:  Guan-Hua Qiao; Fei Zhao; Shuang Cheng; Min-Hua Luo
Journal:  Virol Sin       Date:  2016-04-21       Impact factor: 4.327

3.  Beneficial effect of human umbilical cord-derived mesenchymal stem cells on an endotoxin-induced rat model of preeclampsia.

Authors:  Lihua Fu; Yongjun Liu; Dan Zhang; Jiang Xie; Hongbo Guan; Tao Shang
Journal:  Exp Ther Med       Date:  2015-09-11       Impact factor: 2.447

4.  Comparison of Preterm and Term Wharton's Jelly-Derived Mesenchymal Stem Cell Properties in Different Oxygen Tensions.

Authors:  Saloni Balgi-Agarwal; Caitlyn Winter; Alexis Corral; Shamimunisa B Mustafa; Peter Hornsby; Alvaro Moreira
Journal:  Cells Tissues Organs       Date:  2018-06-27       Impact factor: 2.481

Review 5.  Wharton's jelly derived mesenchymal stem cells: future of regenerative medicine? Recent findings and clinical significance.

Authors:  Ilona Kalaszczynska; Katarzyna Ferdyn
Journal:  Biomed Res Int       Date:  2015-03-15       Impact factor: 3.411

Review 6.  Impact of umbilical cord blood-derived mesenchymal stem cells on cardiovascular research.

Authors:  Santiago Roura; Josep Maria Pujal; Carolina Gálvez-Montón; Antoni Bayes-Genis
Journal:  Biomed Res Int       Date:  2015-03-10       Impact factor: 3.411

7.  Suspension Culture Alters Insulin Secretion in Induced Human Umbilical Cord Matrix-Derived Mesenchymal Cells.

Authors:  Fatemeh Seyedi; Alireza Farsinejad; Seyed Amirmahdi Nematollahi-Mahani; Touba Eslaminejad; Seyed Noureddin Nematollahi-Mahani
Journal:  Cell J       Date:  2016-04-04       Impact factor: 2.479

8.  Standardizing Umbilical Cord Mesenchymal Stromal Cells for Translation to Clinical Use: Selection of GMP-Compliant Medium and a Simplified Isolation Method.

Authors:  J Robert Smith; Kyle Pfeifer; Florian Petry; Natalie Powell; Jennifer Delzeit; Mark L Weiss
Journal:  Stem Cells Int       Date:  2016-02-04       Impact factor: 5.443

9.  Improvement of renal function after human umbilical cord mesenchymal stem cell treatment on chronic renal failure and thoracic spinal cord entrapment: a case report.

Authors:  Ahmad Jabir Rahyussalim; Ifran Saleh; Tri Kurniawati; Andi Praja Wira Yudha Lutfi
Journal:  J Med Case Rep       Date:  2017-11-30

Review 10.  Umbilical Cord as Prospective Source for Mesenchymal Stem Cell-Based Therapy.

Authors:  Irina Arutyunyan; Andrey Elchaninov; Andrey Makarov; Timur Fatkhudinov
Journal:  Stem Cells Int       Date:  2016-08-29       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.